Related Experiment Video

Updated: Aug 11, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

Interventional approach to recurrent myocardial infarction in HIV-1 infection

James J Glazier1, J Richard Spears, Melvin C Murphy

  • 1Department of Medicine, Harper University Hospital, Detroit, Michigan 48201, USA. jamesjglazier@hotmail.com

Journal of Interventional Cardiology
|February 18, 2006
PubMed

Insights

This case study details recurrent myocardial infarction in a patient with HIV-1 infection. Successful treatment was achieved using intracoronary stent placement for both cardiac events.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Interventional Cardiology

Background:

  • Human Immunodeficiency Virus (HIV-1) infection is associated with an increased risk of cardiovascular disease.
  • Recurrent myocardial infarction (MI) presents a significant clinical challenge, particularly in specific patient populations.

Observation:

  • A case of recurrent myocardial infarction in two distinct coronary territories is presented.
  • The patient had a known history of Human Immunodeficiency Virus type 1 (HIV-1) infection.

Findings:

  • Both instances of myocardial infarction were successfully treated with intracoronary stent placement.
  • Angiographic and clinical success was achieved on both occasions, demonstrating the efficacy of interventional procedures.

Implications:

  • This case highlights the importance of considering cardiovascular complications in patients with HIV-1.
  • Intracoronary stent placement is an effective therapeutic option for managing recurrent myocardial infarction in this population.
  • Further research may explore the specific mechanisms linking HIV-1 infection to accelerated atherosclerosis and recurrent MI.

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...